NCT02509871View on ClinicalTrials.gov

Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Hormonal TherapyBreast Cancer
Interventions
OTHER

Body composition measurement

DXA, impedance

Trial Locations (1)

63011

Centre Jean Perrin, Clermont-Ferrand

All Listed Sponsors
lead

Centre Jean Perrin

OTHER

NCT02509871 - Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2) | Biotech Hunter | Biotech Hunter